Chia-Lun Chang

Personal profile

Education

2000-2007 M.D., School of Medicine, National Cheng Kung University

Experience

Assistant Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
2010.08-2012.07 Chief Resident Physician, Linkou Chang Gung Memorial Hospital
2007.08-2010.07 Resident Physician, Linkou Chang Gung Memorial Hospital

Fingerprint Dive into the research topics where Chia-Lun Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

35 Similar Profiles

Chemoradiotherapy Medicine & Life Sciences

Radiotherapy Medicine & Life Sciences

Intensity-Modulated Radiotherapy Medicine & Life Sciences

Propensity Score Medicine & Life Sciences

Survival Medicine & Life Sciences

Thorax Medicine & Life Sciences

Taiwan Medicine & Life Sciences

Hepatocellular Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2020

1 Finished
1 Active

新聘教師研究補助

Chang, C.

11/1/18 → 10/31/20

Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty

雙打擊在瀰漫大B細胞淋巴瘤所扮演的角色-致病機轉與臨床特色之探討-MCL1蛋白在雙打擊瀰漫大B細胞淋巴瘤的表現及其臨床的角色

Chang, C.

1/1/19 → 12/1/19

Project: A - Government Institution › d - Ministry of Education

Research Output 2012 2019

305 Citations
12 h-Index
26 Article
1 Comment/debate

Three-dimensional conformal radiotherapy-based or intensity-modulated radiotherapy-based concurrent chemoradiotherapy in patients with thoracic esophageal squamous cell carcinoma

Lin, W. C., Chang, C. L., Hsu, H. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Oct 1 2019, In : Cancers. 11, 10, 1529.

Research output: Contribution to journal › Article

Open Access

Conformal Radiotherapy

Intensity-Modulated Radiotherapy

Chemoradiotherapy

Thorax

Radiotherapy

7 Citations (Scopus)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy

Hsieh, M. C., Chang, W. W., Yu, H. H., Lu, C. Y., Chang, C. L., Chow, J. M., Chen, S. U., Cheng, Y. & Wu, S. Y., Jun 1 2018, In : Cancer Medicine. 7, 6, p. 2328-2338 11 p.

Research output: Contribution to journal › Article

Adjuvant Radiotherapy

Adjuvant Chemoradiotherapy

Adjuvant Chemotherapy

Adenocarcinoma

Chemoradiotherapy

5 Citations (Scopus)

Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment

Yen, Y. C., Hsu, H. L., Chang, J. H., Lin, W. C., Chang, Y. C., Chang, C. L., Chow, J. M., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Jan 1 2018, (Accepted/In press) In : Radiotherapy and Oncology.

Research output: Contribution to journal › Article

Epidermal Growth Factor Receptor

Protein-Tyrosine Kinases

Radiotherapy

Thorax

Therapeutics

6 Citations (Scopus)

Fucoidan inhibits radiation-induced pneumonitis and lung fibrosis by reducing inflammatory cytokine expression in lung tissues

Yu, H. H., Chengchuan, E. K. O., Chang, C. L., Yuan, K. S. P., Wu, A. T. H., Shan, Y. S. & Wu, S. Y., Oct 19 2018, In : Marine Drugs. 16, 10, md16100392.

Research output: Contribution to journal › Article

Radiation Pneumonitis

Fibrosis

Cytokines

Lung

Radiotherapy

3 Citations (Scopus)

Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

Lin, Y. K., Hsieh, M. C., Chang, C. L., Chow, J. M., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Nov 1 2018, In : Radiotherapy and Oncology. 129, 2, p. 326-332 7 p.

Research output: Contribution to journal › Article

Intensity-Modulated Radiotherapy

Propensity Score

Adenocarcinoma

Cohort Studies

Drug Therapy